A bankruptcy court has approved the sale of 23andMe to TTAM Research Institute. In an email sent out to customers on Tuesday, ...

More than 90% of patients achieved clinically meaningful weight reduction compared to placebo in a phase 3 trial of ecnoglutide.

Fintel reports that on June 17, 2025, Morgan Stanley downgraded their outlook for Sarepta Therapeutics (NasdaqGS:SRPT) from ...

Singapore , June 05, 2025 (GLOBE NEWSWIRE) -- YY Group Holding Limited (NASDAQ: YYGH) (“YY Group”, “YYGH”, or the “Company”), is pleased to announce the acquisition of Uniforce ...

The loss of the Y chromosome in tumour cells is linked to poor outcomes for people with cancer 1, but this genetic alteration might also compromise immune cells that would otherwise fight the ...

The cancer cells of some men feature a striking mutation: their Y chromosome is missing altogether. Now, tantalizing research suggests that this mutation can spread ‘contagiously’ from tumour ...

A new paper published in Nature on June 4 shines light on how an enigmatic part of male aging—the loss of Y chromosomes—is connected with a higher risk of dying from cancer.. In an analysis of ...

When cancer cells in male patients and immune cells in their tumors both lose the Y chromosome, those patients tend to experience poorer outcomes than patients without Y chromosome loss, according ...

On May 14, 2025, Works and Transport Minister Mr Fred Byamukama ordered the suspension of YY Coach operations following two serious road crashes involving the company’s buses ...

TUCSON, Ariz. (KVOA) - University of Arizona scientists have discovered that the loss of the Y chromosome in men's cells may make it more difficult to survive cancer.

University of Haifa study shows how genetic "imprinting" determines whether rare syndrome leads to autism or psychosis, offering new model for personalized psychiatry.

UCB, a global biopharmaceutical company, today announced that the Phase 3 study investigating the safety and efficacy of adjunctive fenfluramine in CDKL5 deficiency disorder (CDD) met its primary and ...